https://scholars.lib.ntu.edu.tw/handle/123456789/551090
標題: | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4 | 作者: | Chan H.L.Y. Chen C.J. Omede O. Al Qamish J. Al Naamani K. Bane A. Tan S.S. Simonova M. Cardenas I. Derbala M. Akin O. Phillips R.O. Abdelmageed M.K. Abdulla M. Adda D. Al Baqali A. Al Dweik N. Al Ejji K. Al ghazzawi I. Al Kaabi S. Al Sadadi M. Al Salman J. AlBadri M. Al-Busafi S.A. Al-Romaihi H.E. Ampofo W. Antonov K. Anyaike C. Arome F. Blach S. Borodo M.M. Brandon S.M. Bright B. Butt M.T. DING-SHINN CHEN PEI-JER CHEN Chien R.N. Chuang W.L. Cuellar D. Elbardiny A.A. Estes C. Farag E. Fung J. Gamkrelidze I. Garcia V. Genov J. Ghandour Z. Ghuloom M. Gomez B. Gunter J. Habeeb J. Hajelssedig O. Hamoudi W. Himatt S.M. Hrstic I. Hu C.C. Huang C.F. Hui Y.T. Jahis R. Jelev D. John A.K. Kaliaskarova K.S. Kamel Y. JIA-HORNG KAO Khamis J. Khattabi H. Khoudri I. Konysbekova A. Kotzev I. Lai M.S. Lao W.C. Layden J. Lee M.H. Lesi O. Li M. Lo A. Loo C.K. Lukšić B. Maaroufi A. Malu A.O. Mateva L. Mitova R. Mohamed R. Morović M. Murphy K. Mustapha B. Nersesov A. Ngige E. Njouom R. Njoya O. Nonković D. Obekpa S. Oguche S. Okolo E.E. Omuemu C. Ondoa P. Opare-Sem O. Owusu-Ofori S. Prokopenko Y.N. Razavi H. Razavi-Shearer D. Razavi-Shearer K. Redae B. Reic T. Rinke de Wit T. Rios C. Robbins S. Roberts L.R. Sanad S.J. Schmelzer J.D. Sharma M. TUNG-HUNG SU Sultan K. Tchernev K. Tsang O.T.Y. Tsang S. Tzeuton C. Ugoeze S. Uzochukwu B. Vi R. Vince A. Wani H.U. Wong V.W.S. Workneh A. Yacoub R. Yesmembetov K.I. Youbi M. Yuen M.F. Nde H. |
公開日期: | 2017 | 出版社: | Blackwell Publishing Ltd | 卷: | 24 | 起(迄)頁: | 25-43 | 來源出版物: | Journal of Viral Hepatitis | 摘要: | Factors influencing the morbidity and mortality associated with viremic hepatitis C virus (HCV) infection change over time and place, making it difficult to compare reported estimates. Models were developed for 17 countries (Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong, Jordan, Kazakhstan, Malaysia, Morocco, Nigeria, Qatar and Taiwan) to quantify and characterize the viremic population as well as forecast the changes in the infected population and the corresponding disease burden from 2015 to 2030. Model inputs were agreed upon through expert consensus, and a standardized methodology was followed to allow for comparison across countries. The viremic prevalence is expected to remain constant or decline in all but four countries (Ethiopia, Ghana, Jordan and Oman); however, HCV-related morbidity and mortality will increase in all countries except Qatar and Taiwan. In Qatar, the high-treatment rate will contribute to a reduction in total cases and HCV-related morbidity by 2030. In the remaining countries, however, the current treatment paradigm will be insufficient to achieve large reductions in HCV-related morbidity and mortality. ? 2017 The Authors. Journal of Viral Hepatitis Published by John Wiley & Sons Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032955067&doi=10.1111%2fjvh.12760&partnerID=40&md5=299f52fab14d985cbcd5439eeba58962 https://scholars.lib.ntu.edu.tw/handle/123456789/551090 |
ISSN: | 1352-0504 | DOI: | 10.1111/jvh.12760 | SDG/關鍵字: | peginterferon; proteinase inhibitor; ribavirin; antivirus agent; all cause mortality; Article; Bahrain; Bulgaria; Cameroon; clinical protocol; Colombia; consensus; Croatia; disease association; Dominican Republic; Ethiopia; Ghana; global disease burden; hepatitis C; Hong Kong; human; Jordan; Kazakhstan; Malaysia; medical expert; methodology; morbidity; Morocco; mortality; Nigeria; nonhuman; prevalence; priority journal; Qatar; reinfection; standard; statistical model; Taiwan; viremia; chronic hepatitis C; comparative study; global health; health care policy; incidence; mortality; statistical model; viremia; Antiviral Agents; Global Health; Health Policy; Hepatitis C, Chronic; Humans; Incidence; Models, Statistical; Prevalence; Viremia |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。